Krystal Biotech, Inc. Profile Avatar - Palmy Investing

Krystal Biotech, Inc.

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical…
Biotechnology
US, Pittsburgh [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Competitor Private? Source Accuracy Country City
Apellis Pharmaceuticals, Inc. FMP High United States Waltham
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of KRYS's Analysis
CIK: 1711279 CUSIP: 501147102 ISIN: US5011471027 LEI: - UEI: -
Secondary Listings
KRYS has no secondary listings inside our databases.